A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.3389/fmicb.2019.01667 http://hdl.handle.net/11449/185957 |
Resumo: | Currently 75-88% of fungal infections are caused by Candida species, and Candida albicans is the main microorganism that causes these infections, especially oral candidiasis. An option for treatment involves the use of the antifungal peptide Histatin 5 (Hst 5), which is naturally found in human saliva but undergoes rapid degradation when present in the oral cavity, its site of action. For this reason, it is important to develop a way of applying this peptide to the oral lesions, which promotes the gradual release of the peptide. In the present study, we have evaluated the development of liposomes of different lipid compositions, loaded with the peptide as a way to promote its release slowly and gradually, preserving its antifungal potential. For this, the peptide 0WHistatin 5, an analog of the peptide Hst 5, was synthesized, which contains the amino acid tryptophan in its sequence. The solid phase synthesis method was used, followed by cleavage and purification. The liposomes were produced by thin film hydration technique in three different lipid compositions, F1, F2, and F3 and were submitted to an extrusion and sonication process to standardize the size and study the best technique for their production. The liposomes were characterized by dynamic light scattering, and tests were performed to determine the encapsulation efficiency, release kinetics, stability, and evaluation of antifungal activity. The extruded liposomes presented average size in the range of 100 nm, while sonicated liposomes presented a smaller size in the range of 80 nm. The encapsulation efficiency was higher for the sonicated liposomes, being 34.5% for F1. The sonicated F3 presented better stability when stored for 60 days at 4 degrees C. The liposomes showed the ability to release the peptide for the total time of 96 h, with the first peak after 5 h, and a further increase of the released after 30 h. Time-kill assay showed that the liposomes were able to control yeast growth for 72 h. The data suggest that the liposomes loaded with 0WHistatin 5 maintained the action of the peptide and were able to limit the growth of C. albicans, being a suitable system for use in the treatment of oral candidiasis. |
id |
UNSP_e34e9d97dfa60939d3c5c5deb14c4295 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/185957 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicansantifungal systemoral candidiasisCandida albicansHistatin 5liposomesCurrently 75-88% of fungal infections are caused by Candida species, and Candida albicans is the main microorganism that causes these infections, especially oral candidiasis. An option for treatment involves the use of the antifungal peptide Histatin 5 (Hst 5), which is naturally found in human saliva but undergoes rapid degradation when present in the oral cavity, its site of action. For this reason, it is important to develop a way of applying this peptide to the oral lesions, which promotes the gradual release of the peptide. In the present study, we have evaluated the development of liposomes of different lipid compositions, loaded with the peptide as a way to promote its release slowly and gradually, preserving its antifungal potential. For this, the peptide 0WHistatin 5, an analog of the peptide Hst 5, was synthesized, which contains the amino acid tryptophan in its sequence. The solid phase synthesis method was used, followed by cleavage and purification. The liposomes were produced by thin film hydration technique in three different lipid compositions, F1, F2, and F3 and were submitted to an extrusion and sonication process to standardize the size and study the best technique for their production. The liposomes were characterized by dynamic light scattering, and tests were performed to determine the encapsulation efficiency, release kinetics, stability, and evaluation of antifungal activity. The extruded liposomes presented average size in the range of 100 nm, while sonicated liposomes presented a smaller size in the range of 80 nm. The encapsulation efficiency was higher for the sonicated liposomes, being 34.5% for F1. The sonicated F3 presented better stability when stored for 60 days at 4 degrees C. The liposomes showed the ability to release the peptide for the total time of 96 h, with the first peak after 5 h, and a further increase of the released after 30 h. Time-kill assay showed that the liposomes were able to control yeast growth for 72 h. The data suggest that the liposomes loaded with 0WHistatin 5 maintained the action of the peptide and were able to limit the growth of C. albicans, being a suitable system for use in the treatment of oral candidiasis.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)UNESP Sao Paulo State Univ, Inst Chem, Dept Biochem & Chem Technol, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Drugs & Med, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Biol Sci, Araraquara, BrazilUNESP Sao Paulo State Univ, Inst Chem, Dept Biochem & Chem Technol, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Drugs & Med, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Biol Sci, Araraquara, BrazilFAPESP: 2013/19370-2FAPESP: 2018/03018-1Frontiers Media SaUniversidade Estadual Paulista (Unesp)Zambom, Carolina R. [UNESP]Fonseca, Fauller H. da [UNESP]Crusca Jr, Edson [UNESP]Silva, Patricia B. da [UNESP]Pavan, Fernando R. [UNESP]Chorilli, Marius [UNESP]Garrido, Saulo S. [UNESP]2019-10-04T12:40:01Z2019-10-04T12:40:01Z2019-07-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article11http://dx.doi.org/10.3389/fmicb.2019.01667Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 11 p., 2019.1664-302Xhttp://hdl.handle.net/11449/18595710.3389/fmicb.2019.01667WOS:000477791800001Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengFrontiers In Microbiologyinfo:eu-repo/semantics/openAccess2024-06-24T13:46:01Zoai:repositorio.unesp.br:11449/185957Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T20:15:15.536732Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
title |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
spellingShingle |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans Zambom, Carolina R. [UNESP] antifungal system oral candidiasis Candida albicans Histatin 5 liposomes |
title_short |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
title_full |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
title_fullStr |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
title_full_unstemmed |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
title_sort |
A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans |
author |
Zambom, Carolina R. [UNESP] |
author_facet |
Zambom, Carolina R. [UNESP] Fonseca, Fauller H. da [UNESP] Crusca Jr, Edson [UNESP] Silva, Patricia B. da [UNESP] Pavan, Fernando R. [UNESP] Chorilli, Marius [UNESP] Garrido, Saulo S. [UNESP] |
author_role |
author |
author2 |
Fonseca, Fauller H. da [UNESP] Crusca Jr, Edson [UNESP] Silva, Patricia B. da [UNESP] Pavan, Fernando R. [UNESP] Chorilli, Marius [UNESP] Garrido, Saulo S. [UNESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) |
dc.contributor.author.fl_str_mv |
Zambom, Carolina R. [UNESP] Fonseca, Fauller H. da [UNESP] Crusca Jr, Edson [UNESP] Silva, Patricia B. da [UNESP] Pavan, Fernando R. [UNESP] Chorilli, Marius [UNESP] Garrido, Saulo S. [UNESP] |
dc.subject.por.fl_str_mv |
antifungal system oral candidiasis Candida albicans Histatin 5 liposomes |
topic |
antifungal system oral candidiasis Candida albicans Histatin 5 liposomes |
description |
Currently 75-88% of fungal infections are caused by Candida species, and Candida albicans is the main microorganism that causes these infections, especially oral candidiasis. An option for treatment involves the use of the antifungal peptide Histatin 5 (Hst 5), which is naturally found in human saliva but undergoes rapid degradation when present in the oral cavity, its site of action. For this reason, it is important to develop a way of applying this peptide to the oral lesions, which promotes the gradual release of the peptide. In the present study, we have evaluated the development of liposomes of different lipid compositions, loaded with the peptide as a way to promote its release slowly and gradually, preserving its antifungal potential. For this, the peptide 0WHistatin 5, an analog of the peptide Hst 5, was synthesized, which contains the amino acid tryptophan in its sequence. The solid phase synthesis method was used, followed by cleavage and purification. The liposomes were produced by thin film hydration technique in three different lipid compositions, F1, F2, and F3 and were submitted to an extrusion and sonication process to standardize the size and study the best technique for their production. The liposomes were characterized by dynamic light scattering, and tests were performed to determine the encapsulation efficiency, release kinetics, stability, and evaluation of antifungal activity. The extruded liposomes presented average size in the range of 100 nm, while sonicated liposomes presented a smaller size in the range of 80 nm. The encapsulation efficiency was higher for the sonicated liposomes, being 34.5% for F1. The sonicated F3 presented better stability when stored for 60 days at 4 degrees C. The liposomes showed the ability to release the peptide for the total time of 96 h, with the first peak after 5 h, and a further increase of the released after 30 h. Time-kill assay showed that the liposomes were able to control yeast growth for 72 h. The data suggest that the liposomes loaded with 0WHistatin 5 maintained the action of the peptide and were able to limit the growth of C. albicans, being a suitable system for use in the treatment of oral candidiasis. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-10-04T12:40:01Z 2019-10-04T12:40:01Z 2019-07-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3389/fmicb.2019.01667 Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 11 p., 2019. 1664-302X http://hdl.handle.net/11449/185957 10.3389/fmicb.2019.01667 WOS:000477791800001 |
url |
http://dx.doi.org/10.3389/fmicb.2019.01667 http://hdl.handle.net/11449/185957 |
identifier_str_mv |
Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 11 p., 2019. 1664-302X 10.3389/fmicb.2019.01667 WOS:000477791800001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Frontiers In Microbiology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
11 |
dc.publisher.none.fl_str_mv |
Frontiers Media Sa |
publisher.none.fl_str_mv |
Frontiers Media Sa |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808129179599765504 |